Common Stock, Shares Authorized of AVAI BIO, INC. from 31 Mar 2018 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
AVAI BIO, INC. quarterly Common Stock, Shares Authorized in shares history and change rate from 31 Mar 2018 to 31 Dec 2025.
  • AVAI BIO, INC. Common Stock, Shares Authorized for the quarter ending 31 Dec 2025 was 500,000,000, unchanged year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Change (%)

AVAI BIO, INC. Quarterly Common Stock, Shares Authorized (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 500,000,000 0 0% 31 Dec 2025 10-Q 12 Feb 2026 2026 Q3
Q3 2025 500,000,000 0 0% 30 Sep 2025 10-Q 14 Nov 2025 2026 Q2
Q2 2025 500,000,000 0 0% 30 Jun 2025 10-Q 12 Aug 2025 2026 Q1
Q1 2025 500,000,000 0 0% 31 Mar 2025 10-Q 12 Feb 2026 2026 Q3
Q4 2024 500,000,000 0 0% 31 Dec 2024 10-Q 07 Feb 2025 2025 Q3
Q3 2024 500,000,000 30 Sep 2024 10-Q/A 21 Jan 2025 2025 Q2
Q2 2024 500,000,000 0 0% 30 Jun 2024 10-Q/A 21 Jan 2025 2025 Q1
Q1 2024 500,000,000 0 0% 31 Mar 2024 10-K 08 Jul 2025 2025 FY
Q4 2023 500,000,000 +250,000,000 +100% 31 Dec 2023 10-Q 14 Feb 2024 2024 Q3
Q2 2023 500,000,000 +250,000,000 +100% 30 Jun 2023 10-Q 16 Aug 2023 2023 Q1
Q1 2023 500,000,000 0 0% 31 Mar 2023 10-K/A 19 Feb 2025 2024 FY
Q4 2022 250,000,000 0 0% 31 Dec 2022 10-Q 14 Feb 2023 2023 Q3
Q3 2022 250,000,000 0 0% 30 Sep 2022 10-Q 10 Nov 2022 2023 Q2
Q2 2022 250,000,000 0 0% 30 Jun 2022 10-Q 19 Aug 2022 2023 Q1
Q1 2022 500,000,000 +250,000,000 +100% 31 Mar 2022 10-K/A 13 Jul 2023 2022 FY
Q4 2021 250,000,000 0 0% 31 Dec 2021 10-Q 14 Feb 2022 2022 Q3
Q3 2021 250,000,000 0 0% 30 Sep 2021 10-Q 15 Nov 2021 2022 Q2
Q2 2021 250,000,000 +175,000,000 +233% 30 Jun 2021 10-Q 23 Aug 2021 2021 Q1
Q1 2021 250,000,000 0 0% 31 Mar 2021 10-K 29 Jun 2022 2022 FY
Q4 2020 250,000,000 +175,000,000 +233% 31 Dec 2020 10-Q 18 Feb 2021 2021 Q3
Q3 2020 250,000,000 +175,000,000 +233% 30 Sep 2020 10-Q 15 Nov 2021 2022 Q2
Q2 2020 75,000,000 0 0% 30 Jun 2020 10-Q 20 Aug 2020 2021 Q1
Q1 2020 250,000,000 +175,000,000 +233% 31 Mar 2020 10-Q 18 Feb 2021 2021 Q3
Q4 2019 75,000,000 0 0% 31 Dec 2019 10-Q 04 Feb 2020 2020 Q3
Q3 2019 75,000,000 0 0% 30 Sep 2019 10-Q 13 Nov 2019 2020 Q2
Q2 2019 75,000,000 0 0% 30 Jun 2019 10-Q/A 17 Oct 2019 2020 Q1
Q1 2019 75,000,000 0 0% 31 Mar 2019 10-K 13 Aug 2020 2020 FY
Q4 2018 75,000,000 31 Dec 2018 10-Q 17 Jan 2019 2019 Q3
Q3 2018 75,000,000 30 Sep 2018 10-Q 14 Nov 2018 2019 Q2
Q2 2018 75,000,000 30 Jun 2018 10-Q 25 Jul 2018 2019 Q1
Q1 2018 75,000,000 31 Mar 2018 10-K 15 Jul 2019 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.